Summary
Amino acid supplements are recognized to be essential for the management of a number of inherited metabolic disorders but their use in some other conditions is more controversial.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- MELAS:
-
mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes
- NMDA:
-
N-methyl-D-aspartate
- PKU:
-
phenylketonuria
References
de Koning TJ, Duran M, Dorland L, et al (1998) Beneficial effects of l-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency. Ann Neurol 44(2): 261–265.
Koch R, Moseley KD, Yano S, et al (2003) Large neutral amino acid therapy and phenylketonuria: a promising approach to treatment. Mol Genet Metab 79(2): 110–113.
Koga Y, Akita Y, Nishioka J, et al (2005) l-Arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64(4): 710–712.
Kolker S, Garbade SF, Greenberg CR, et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res (in press)
Matsuo S, Inoue F, Takeuchi Y, et al (1995) Efficacy of tryptophan for the treatment of nonketotic hyperglycinemia: a new therapeutic approach for modulating the N-methyl-d-aspartate receptor. Pediatrics 95(1): 142–146.
Author information
Authors and Affiliations
Additional information
Communicating editor: Jean-Marie Saudubray
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Walter, J.H., MacDonald, A. The use of amino acid supplements in inherited metabolic disease. J Inherit Metab Dis 29, 279–280 (2006). https://doi.org/10.1007/s10545-006-0357-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0357-1